Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP
- PMID: 22266862
- DOI: 10.1038/onc.2011.614
Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP
Abstract
Glioblastoma is the most common primary brain tumor with a very poor prognosis, calling for novel treatment strategies. Here, we provide first evidence that histone deacetylase inhibitors (HDACI) prime glioblastoma cells for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) -induced apoptosis at least in part by c-myc-mediated downregulation of cellular FLICE-inhibitory protein (cFLIP). Pretreatment with distinct HDACI (MS275, suberoylanilide hydroxamic acid, valproic acid) significantly enhances TRAIL-induced apoptosis in several glioblastoma cell lines. Monitoring a panel of apoptosis-regulatory proteins revealed that MS275 reduces the expression of cFLIP(L) and cFLIP(S). This leads to decreased recruitment of cFLIP(L) and cFLIP(S) and increased activation of caspase-8 to the TRAIL death-inducing signaling complex, resulting in enhanced cleavage of caspase-8, -9 and -3 and caspase-dependent apoptosis. Also, MS275 promotes TRAIL-triggered processing of Bid, activation of Bax, loss of mitochondrial membrane potential and release of cytochrome c. MS275-mediated downregulation of cFLIP occurs at the mRNA level independent of proteasome- or caspase-mediated degradation, and is preceded by upregulation of nuclear levels of c-myc, a transcriptional repressor of cFLIP. Notably, MS275 causes increased binding of c-myc to the cFLIP promoter and reduces cFLIP promoter activity. Indeed, knockdown of c-myc partially rescues cFLIP(L) from MS275-inferred downregulation and significantly decreases TRAIL- and MS275-induced apoptosis. Also, overexpression of cFLIP(L) or cFLIP(S) significantly reduces MS275- and TRAIL-induced apoptosis. Importantly, MS275 sensitizes primary cultured glioblastoma cells towards TRAIL and cooperates with TRAIL to reduce long-term clonogenic survival of glioblastoma cells and to suppress glioblastoma growth in vivo underscoring the clinical relevance of this approach. Thus, these findings demonstrate that HDACI represent a promising strategy to prime glioblastoma for TRAIL-induced apoptosis by targeting cFLIP.
Similar articles
-
Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis.Clin Cancer Res. 2011 Jun 15;17(12):4019-30. doi: 10.1158/1078-0432.CCR-11-0075. Epub 2011 Apr 27. Clin Cancer Res. 2011. PMID: 21525171
-
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.Oncogene. 2006 Dec 7;25(58):7618-34. doi: 10.1038/sj.onc.1209738. Epub 2006 Sep 18. Oncogene. 2006. PMID: 16983347
-
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.Int J Mol Med. 2005 Dec;16(6):1125-38. Int J Mol Med. 2005. PMID: 16273296
-
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.Invest New Drugs. 2005 Mar;23(2):99-109. doi: 10.1007/s10637-005-5854-9. Invest New Drugs. 2005. PMID: 15744585 Review.
-
Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.Vitam Horm. 2004;67:453-83. doi: 10.1016/S0083-6729(04)67023-3. Vitam Horm. 2004. PMID: 15110190 Review.
Cited by
-
Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity.Biology (Basel). 2022 Feb 16;11(2):313. doi: 10.3390/biology11020313. Biology (Basel). 2022. PMID: 35205179 Free PMC article. Review.
-
TRAIL Conjugated Silver Nanoparticle Synthesis, Characterization and Therapeutic Effects on HT-29 Colon Cancer Cells.Iran J Pharm Res. 2021 Spring;20(2):45-56. doi: 10.22037/ijpr.2020.112069.13514. Iran J Pharm Res. 2021. PMID: 34567145 Free PMC article.
-
Characterization of Histone Deacetylase Mechanisms in Cancer Development.Front Oncol. 2021 Jul 29;11:700947. doi: 10.3389/fonc.2021.700947. eCollection 2021. Front Oncol. 2021. PMID: 34395273 Free PMC article. Review.
-
Epigenetic Deregulation of Apoptosis in Cancers.Cancers (Basel). 2021 Jun 27;13(13):3210. doi: 10.3390/cancers13133210. Cancers (Basel). 2021. PMID: 34199020 Free PMC article. Review.
-
Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair.Mol Neurobiol. 2021 Aug;58(8):4169-4177. doi: 10.1007/s12035-021-02406-w. Epub 2021 May 5. Mol Neurobiol. 2021. PMID: 33954904 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials